4//SEC Filing
Gonyer David A 4
Accession 0001209191-20-015796
CIK 0001403708other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 8:25 PM ET
Size
5.8 KB
Accession
0001209191-20-015796
Insider Transaction Report
Form 4
Evoke Pharma IncEVOK
Gonyer David A
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2020-02-28+325,000→ 325,000 totalExercise: $1.23Exp: 2030-02-27→ Common Stock (325,000 underlying)
Footnotes (1)
- [F1]One-half of the stock options will vest in 48 equal monthly installments over the four-year period beginning on January 1, 2020, subject to the reporting person's continued service to the issuer through each such vesting date. The other one-half of the stock options will vest in 48 equal monthly installments over the four-year period beginning on the date, if any, on which the U.S. Food and Drug Administration approves the Issuer's new drug application for Gimoti, subject to the reporting person's continued service to the issuer through each such vesting date.
Documents
Issuer
Evoke Pharma Inc
CIK 0001403708
Entity typeother
Related Parties
1- filerCIK 0001578768
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 8:25 PM ET
- Size
- 5.8 KB